• Tracerco, part of the FTSE100 company, Johnson Matthey Plc, has added to its award-winning range of radiation monitors with two new Personal Electronic Dosimeters (PEDs) – the PED-ER and PED-ER+. With an extended dose rate range of up to 1 Sv/h (100 R/h) and a light, compact, robust and reliable design, the PED-ER and PED-ER+ provide the ultimate radiation monitoring, measurement and management solution for those working in challenging environments.

  • Med-Eng®, a brand of The Safariland Group, today announced it has been awarded a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract to provide the United States Air Force (USAF) with the Med-Eng EOD® 10 bomb suit to protect personnel conducting Explosive Ordnance Disposal (EOD) operations. The USAF selected the EOD 10 suit and accessories through a competitive solicitation process that required meeting the new National Institute of Justice Standard 0117.01 (NIJ Standard) for protection against blast, fragmentation, impact and heat, among many other demanding factors. Under the contract, which has a maximum value of $15 million, the USAF may procure up to 305 EOD 10 bomb suits during the five-year term.

  • Emergent BioSolutions Inc. (NYSE:EBS) today announced the successful completion of the Mutual Recognition Procedure (MRP) for market authorisation of BioThrax® (Anthrax Vaccine Adsorbed) in five Concerned Member States (CMS) within the European Union (EU), including Italy, the Netherlands, Poland, the U.K., and France (where it will be marketed as BaciThrax™). Emergent filed the mutual recognition application based on the existing Marketing Authorisation of BioThrax in Germany granted by the Paul-Ehrlich-Institut. Following the positive MRP outcome, national licences are due to be issued shortly by the five CMS countries.

  • view more news »
  • Follow us on Twitter
  • Subscribe to CBRNe news
cbrne
 
cbrne